Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Argivit is a multi-ingredient dietary supplement developed by Ceres Pharma, specifically through its Italian subsidiary Aesculapius Farmaceutici, designed to provide comprehensive energy and nutritional support. The formulation is a combination of small molecule active ingredients including L-arginine, creatine, L-carnitine, and L-aspartic acid, supplemented with magnesium pidolate, potassium citrate, and a variety of vitamins and minerals. It is primarily indicated for counteracting physical and mental tiredness, supporting muscle function, and maintaining energy metabolism during periods of high demand, seasonal changes, or physical activity. The product line includes specialized versions such as Argivit Focus and Argivit Smart, which are tailored for cognitive support and rapid energy recovery, respectively.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Argivit.